1. Home
  2. MIST vs JUNE Comparison

MIST vs JUNE Comparison

Compare MIST & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • JUNE
  • Stock Information
  • Founded
  • MIST 2003
  • JUNE 1998
  • Country
  • MIST Canada
  • JUNE Singapore
  • Employees
  • MIST N/A
  • JUNE N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • JUNE
  • Sector
  • MIST Health Care
  • JUNE
  • Exchange
  • MIST Nasdaq
  • JUNE Nasdaq
  • Market Cap
  • MIST 98.1M
  • JUNE 83.2M
  • IPO Year
  • MIST N/A
  • JUNE 2024
  • Fundamental
  • Price
  • MIST $0.88
  • JUNE $9.46
  • Analyst Decision
  • MIST Strong Buy
  • JUNE
  • Analyst Count
  • MIST 2
  • JUNE 0
  • Target Price
  • MIST $17.00
  • JUNE N/A
  • AVG Volume (30 Days)
  • MIST 4.5M
  • JUNE 80.2K
  • Earning Date
  • MIST 03-13-2025
  • JUNE 05-10-2025
  • Dividend Yield
  • MIST N/A
  • JUNE N/A
  • EPS Growth
  • MIST N/A
  • JUNE N/A
  • EPS
  • MIST N/A
  • JUNE N/A
  • Revenue
  • MIST N/A
  • JUNE $2,903,179.00
  • Revenue This Year
  • MIST N/A
  • JUNE N/A
  • Revenue Next Year
  • MIST $1,105.43
  • JUNE N/A
  • P/E Ratio
  • MIST N/A
  • JUNE N/A
  • Revenue Growth
  • MIST N/A
  • JUNE N/A
  • 52 Week Low
  • MIST $0.75
  • JUNE $2.75
  • 52 Week High
  • MIST $2.75
  • JUNE $9.90
  • Technical
  • Relative Strength Index (RSI)
  • MIST 30.59
  • JUNE N/A
  • Support Level
  • MIST $1.86
  • JUNE N/A
  • Resistance Level
  • MIST $2.36
  • JUNE N/A
  • Average True Range (ATR)
  • MIST 0.23
  • JUNE 0.00
  • MACD
  • MIST -0.06
  • JUNE 0.00
  • Stochastic Oscillator
  • MIST 7.43
  • JUNE 0.00

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About JUNE Junee Limited Ordinary Shares

Junee Ltd is a holding company that operates through its subsidiary. It is engaged in providing design, fit-out, repair, and maintenance services for commercial and residential buildings. The design services include both the consultation with its staff and the actual design work. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, installing switches, power outlets, telephone wiring, computer outlet covers, and other electrical and wiring works. Repair and maintenance works include, among other things, replacement of fixtures and fittings, repair and maintenance of cupboards and shelves, and repainting walls and ceilings. Geographically, the company derives all of its revenue from its customers in Hong Kong.

Share on Social Networks: